Literature DB >> 23968542

ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responses.

Maria-Luisa del Rio1, Jörg D Seebach, Carlos Fernández-Renedo, Jose-Ignacio Rodriguez-Barbosa.   

Abstract

Xenotransplantation is an innovative field of research with the potential to provide us with an alternative source of organs to face the severe shortage of human organ donors. For several reasons, pigs have been chosen as the most suitable source of organs and tissues for transplantation in humans. However, porcine xenografts undergo cellular immune responses representing a major barrier to their acceptance and normal functioning. Innate and adaptive xenogeneic immunity is mediated by both the recognition of xenogeneic tissue antigens and the lack of inhibition due to molecular cross-species incompatibilities of regulatory pathways. Therefore, the delivery of immunoreceptor tyrosine-based inhibitory motif (ITIM)-dependent and related negative signals to control innate (NK cells, macrophages) and adaptive T and B cells might overcome cell-mediated xenogeneic immunity. The proof of this concept has already been achieved in vitro by the transgenic overexpression of human ligands of several inhibitory receptors in porcine cells resulting in their resistance against xenoreactivity. Consequently, several transgenic pigs expressing tissue-specific human ligands of inhibitory coreceptors (HLA-E, CD47) or soluble competitors of costimulation (belatacept) have already been generated. The development of these robust and innovative approaches to modulate human anti-pig cellular immune responses, complementary to conventional immunosuppression, will help to achieve long-term xenograft survival. In this review, we will focus on the current strategies to enhance negative signaling pathways for the regulation of undesirable cell-mediated xenoreactive immune responses.
© 2013 John Wiley & Sons A/S.

Entities:  

Keywords:  NK cells; T cells; cellular rejection; co-inhibitory receptors and ligands; immunoreceptor tyrosine-based inhibitory motif; killer immunoglobulin-like receptor; macrophages; xenotransplantation

Mesh:

Substances:

Year:  2013        PMID: 23968542     DOI: 10.1111/xen.12049

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  4 in total

Review 1.  Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.

Authors:  Lin Tian; Anhua Lei; Tianyu Tan; Mengmeng Zhu; Li Zhang; Haibo Mou; Jin Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-09-28

Review 2.  Progress in xenotransplantation: overcoming immune barriers.

Authors:  Megan Sykes; David H Sachs
Journal:  Nat Rev Nephrol       Date:  2022-10-05       Impact factor: 42.439

3.  Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.

Authors:  Zhen Bian; Lei Shi; Ya-Lan Guo; Zhiyuan Lv; Cong Tang; Shuo Niu; Alexandra Tremblay; Mahathi Venkataramani; Courtney Culpepper; Limin Li; Zhen Zhou; Ahmed Mansour; Yongliang Zhang; Andrew Gewirtz; Koby Kidder; Ke Zen; Yuan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-30       Impact factor: 11.205

Review 4.  The Role of NK Cells in Pig-to-Human Xenotransplantation.

Authors:  Gisella Puga Yung; Mårten K J Schneider; Jörg D Seebach
Journal:  J Immunol Res       Date:  2017-12-19       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.